Clinical Trials Logo

Accelerated Phase Chronic Myelogenous Leukemia (CML) clinical trials

View clinical trials related to Accelerated Phase Chronic Myelogenous Leukemia (CML).

Filter by:
  • None
  • Page 1

NCT ID: NCT02782403 Terminated - Clinical trials for Blast Phase Chronic Myelogenous Leukemia (CML)

Axitinib and Bosutinib in Treating Patients With Chronic, Accelerated, or Blastic Phase Chronic Myeloid Leukemia

Start date: March 20, 2017
Phase: Phase 1
Study type: Interventional

This phase I/II trial studies the side effects and best dose of axitinib and bosutinib and how well they work in treating patients with chronic, accelerated, or blastic phase chronic myeloid leukemia. Axitinib and bosutinib may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth.